Correlation Between Centessa Pharmaceuticals and Volaris

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Volaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Volaris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Volaris, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Volaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Volaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Volaris.

Diversification Opportunities for Centessa Pharmaceuticals and Volaris

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Centessa and Volaris is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Volaris in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Volaris and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Volaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Volaris has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Volaris go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and Volaris

Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 1.86 times more return on investment than Volaris. However, Centessa Pharmaceuticals is 1.86 times more volatile than Volaris. It trades about 0.14 of its potential returns per unit of risk. Volaris is currently generating about 0.21 per unit of risk. If you would invest  1,551  in Centessa Pharmaceuticals PLC on August 28, 2024 and sell it today you would earn a total of  159.00  from holding Centessa Pharmaceuticals PLC or generate 10.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Centessa Pharmaceuticals PLC  vs.  Volaris

 Performance 
       Timeline  
Centessa Pharmaceuticals 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Centessa Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.
Volaris 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Volaris are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Volaris unveiled solid returns over the last few months and may actually be approaching a breakup point.

Centessa Pharmaceuticals and Volaris Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Centessa Pharmaceuticals and Volaris

The main advantage of trading using opposite Centessa Pharmaceuticals and Volaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Volaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Volaris will offset losses from the drop in Volaris' long position.
The idea behind Centessa Pharmaceuticals PLC and Volaris pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon